Notable Increase: 2seventy bio (TSVT) Stock Is Soaring On Regulatory Approval Progress
2seventy bio, Incorporated’s (NASDAQ: TSVT) stock value has increased significantly by 22.03% to $4.88 per share. Recent advancements in therapeutic intervention regulatory approval are mostly to blame for this growth. Today, Bristol Myers Squibb and 2seventy Bio (TSVT) jointly announced that the U.S. Food and Drug Administration’s (FDA) Oncologic Drugs Advisory Committee (ODAC) voted in […]
